the disease had its onset from 3-13 days after the injection , lasted 1-5 days , and consisted primarily of urticaria ( 78.3 % ) , macular rash ( 65.2 % ) , angiooedema ( 39.1 % ) , and arthralgia ( 17.4 % ) .
C0042109
urticaria
C0002994
angiooedema